Clinical Trial Update: Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating sirolimus as a monotherapy for antiphospholipid antibody-related thrombocytopenia. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome
• Thrombocytopenia

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Peking University First Hospital | Conditions: Antiphospholipid (aPL)-Positive, Thrombocytopaenia | Phase 4 | Status: RECRUITING